MM-141 regulatory update

FDA granted Orphan Drug designation to MM-141 to treat pancreatic cancer. The tetravalent bispecific antibody targeting insulin-like growth factor 1 (IGF-1) receptor (IGF1R; CD221) and EGFR3 is in Pha...